Basic Information
Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing critical anti-infective treatments for serious and often life-threatening infections. Xellia has been wholly owned by Novo Holdings A/S since 2013 and is headquartered in Copenhagen, Denmark.
Xellia Pharmaceuticals ApS
Copenhagen,TheCapitalRegionofDenmark,Denmark
more than 500 people
January 01, 1903
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios